Related topics: malaria

Genetics underpinning antimalarial drug resistance revealed

The largest genome-wide association study to date of the malaria parasite Plasmodium falciparum unveils a complex genetic architecture that enables the parasite to develop resistance to our most effective antimalarial drug, ...

Are the ethics of synthetic biology fit for purpose?

Synthetic biology promises far reaching solutions to human concerns, from averting climate catastrophes to medical breakthroughs. But are ethics keeping pace with emerging technology? The case study of engineered Artemisinin, ...

New chemistry technique reproduces nature's elusive complexity

(Phys.org)—Scientists at The Scripps Research Institute have shown how to synthesize in the laboratory an important set of natural compounds known as terpenes. The largest class of chemicals made by living organisms, terpenes ...

Transgenic plants against malaria

Scientists have discovered a gene that allows to double the production of artemisinin in the Artemisia annua plant.The artemisinin-based combination therapy (ACT) is the standard treatment for malaria worldwide, endorsed ...

Researchers develop new method to synthesize antimalarial drug

Southwest Research Institute (SwRI) and The University of Texas at San Antonio (UTSA) have developed a method to synthesize the highly potent antimalarial drug artemisinin, which could lead to a more cost-effective treatment ...

page 1 from 2

Artemisinin

Artemisinin ( /ɑrtɨˈmɪsɨnɨn/), also known as Qinghaosu (Chinese: 青蒿素) , and its derivatives are a group of drugs that possess the most rapid action of all current drugs against falciparum malaria. Treatments containing an artemisinin derivative (artemisinin-combination therapies, ACTs) are now standard treatment worldwide for falciparum malaria. The starting compound artemisinin is isolated from the plant Artemisia annua, a herb described in Chinese traditional medicine.

Chemically, artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge. It is believed that this peroxide is responsible for the drug's mechanism of action. No other natural compound with such a peroxide bridge is known.

Use of the drug by itself as a monotherapy is explicitly discouraged by the World Health Organization as there have been signs that malarial parasites are developing resistance to the drug. Therapies that combine artemisinin with some other anti-malarial drug are the preferred treatment for malaria and are both effective and well tolerated in patients. The drug is also increasingly being used in vivax malaria as well as being a topic of research in cancer treatment.

This text uses material from Wikipedia, licensed under CC BY-SA